PUBLISHER: Grand View Research | PRODUCT CODE: 2151523
PUBLISHER: Grand View Research | PRODUCT CODE: 2151523
The Europe brain health supplements market was valued at USD 2.8 billion in 2025 and is projected to grow from USD 3.1 billion in 2026 to USD 7.2 billion by 2033, at a CAGR of 12.7% from 2026 to 2033. The market growth can be attributed to growing awareness of healthy ageing and preventive health is encouraging consumers to incorporate brain health supplements into their daily routines.
In addition, manufacturers are introducing products formulated with vitamins, minerals, omega-3 fatty acids, botanical extracts, and other functional ingredients to address specific cognitive health needs. Product innovation across capsules, tablets, powders, and gummies is further supporting consumer adoption across Europe.
The Europe brain health supplements industry is being shaped by growing consumer awareness of the connection between cognitive health and overall well-being. Consumers are increasingly incorporating brain health products into daily wellness routines to support memory, concentration, focus, mood, mental performance, and healthy ageing. Rising interest in preventive healthcare and self-care is encouraging demand for convenient supplementation alongside balanced diets and healthy lifestyles.
According to Glanbia Nutritionals, the Europe brain-health supplements market is gaining consumer attention as interest in cognitive and mental wellbeing products grows, particularly among younger consumers. 13% of Gen Z consumers in Europe use mental or brain-health supplements, compared with 8% across all age groups, while brain and mood health represented 30% of recent supplement launches in Europe. This focus is also reflected in individual markets, where more than one-third of supplement launches in the UK, Germany, and the Netherlands featured brain- or mood-related positioning. Consumer interest also extends to healthy ageing, with nearly one in four European consumers open to using supplements to support healthy ageing, including cognitive health. In Germany, brain and nervous-system health represented 17% of recent supplement launches, while in the UK, one in five consumers aged 16-44 use supplements to improve mood or manage stress. In addition, 8% of European consumers reported using brain and mood health supplements, indicating established consumer uptake of products positioned around cognitive and mental wellbeing.
Product innovation is further supporting the category. For instance, in May 2026, Seppic introduced Sepibright at Vitafoods Europe, a nootropic ingredient derived from upcycled strawberry leaves and developed for cognitive health applications. The ingredient was positioned around cognitive performance and stress management, with study findings supporting its use in brain health formulations. The launch reflects growing industry interest in naturally sourced, scientifically supported ingredients and demonstrates how ingredient suppliers are developing specialized solutions for the European cognitive wellness market.
Another important trend is the broader positioning of brain health across different stages of life. Consumers are increasingly seeking products that address focus, mental energy, stress, mood, sleep, and healthy ageing rather than memory support alone. Manufacturers are also introducing convenient formats such as gummies, chewables, powders, and functional beverages alongside traditional capsules and tablets. This shift toward targeted benefits and convenient delivery formats is helping brain health supplements become more integrated into everyday wellness and self-care routines.
Europe Brain Health Supplements Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe brain health supplements market report based on product, application, and country.